Literature DB >> 6433194

Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone-releasing hormone.

K E Anderson, I M Spitz, S Sassa, C W Bardin, A Kappas.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6433194     DOI： 10.1056/NEJM198409063111006

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  Recurrent sulphaemoglobinaemia treated with neomycin.

Authors:  D Levine; A T Brunton; A Kruger; M Hersant
Journal:  J R Soc Med       Date:  2000-08       Impact factor: 5.344

2.  Pancreatic tumour with jaundice: good prognosis.

Authors:  G I Diamantopoulos; S A Kapiris; E Anagnostou; C Spiliadi
Journal:  J R Soc Med       Date:  2000-08       Impact factor: 5.344

3.  Two patients with acute intermittent porphyria treated with nafarelin to prevent menstrual exacerbations.

Authors:  S J McNulty; K J Hardy
Journal:  J R Soc Med       Date:  2000-08       Impact factor: 5.344

4.  Pancreaticoduodenectomy after downstaging of pancreatic carcinoma by chemotherapy.

Authors:  J C Hu; K Bradman; M Taylor; M Leslie; M C Parker
Journal:  J R Soc Med       Date:  2000-08       Impact factor: 5.344

5.  The acute porphyrias: a diagnostic and therapeutic challenge in internal and emergency medicine.

Authors:  Paolo Ventura; Maria Domenica Cappellini; Emilio Rocchi
Journal:  Intern Emerg Med       Date:  2009-05-29       Impact factor: 3.397

Review 6.  Hepatic porphyria: A narrative review.

Authors:  Sumant Arora; Steven Young; Sudha Kodali; Ashwani K Singal
Journal:  Indian J Gastroenterol       Date:  2016-10-31

Review 7.  Management of attacks of acute porphyria.

Authors:  A C Laiwah; K E McColl
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

Review 8.  [Porphyrias-what is verified?]

Authors:  U Stölzel; I Kubisch; T Stauch
Journal:  Internist (Berl)       Date:  2018-12       Impact factor: 0.743

9.  An Audit of the Use of Gonadorelin Analogues to Prevent Recurrent Acute Symptoms in Patients with Acute Porphyria in the United Kingdom.

Authors:  Danja Schulenburg-Brand; Tricia Gardiner; Simon Guppy; David C Rees; Penelope Stein; Julian Barth; M Felicity Stewart; Michael Badminton
Journal:  JIMD Rep       Date:  2017-02-21

Review 10.  GnRH agonists and antagonists. Current clinical status.

Authors:  M Filicori; C Flamigni
Journal:  Drugs       Date:  1988-01       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.